Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT01089894
Eligibility Criteria:
Inclusion Criteria:
18F-FLT 1:
1. indeterminate pulmonary nodule(s)
2. has been scheduled an 18F-FDG PET for characterization of their indeterminate pulmonary nodule(s)
3. consent to perform an additional 18F-FLT PET
4. will receive biopsy or surgery for the pulmonary nodule(s)
18F-FLT 2:
1. has pathological proved NSCLC
2. is staged as inoperable advanced NSCLC
3. has been scheduled to receive platinum-based chemotherapy
4. consents to received 18F-FLT PET studies before, at the day before initiation of 2nd cycle of therapy or at 7 days after completion of therapy
18F-FLT 3:
1. has pathological proved NSCLC
2. is staged as inoperable advanced NSCLC
3. has been scheduled to receive EGFR tyrosine kinase inhibitor therapy
4. consents to received 18F-FLT PET studies before, at the 2nd day or at the 7th day of therapy
5. consents to undergo EGFR mutation analysis
Exclusion Criteria:
1. Patients with other known malignancies
2. Age under 18 years
3. Hematological parameters: WBC \< 3000/L or platelet \< 75,000/L (WHO toxicity criteria of grade 1)
4. Abnormal liver function: AST or ALT \> 78U/L (WHO toxicity criteria of grade 1)
5. Renal function: Creatinine \> 2.0 mg/dl (WHO toxicity criteria of grade 1)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT01089894
Study Brief:
Protocol Section:
NCT01089894